Skip to content
Clinical Trials – home

Rheinische Friedrich-Wilhelms-Universitaet Bonn

Verified siteinfo

Germany Venusberg-Campus 1, Venusberg, 53127 Bonn, Germany

  • 181 trials recruiting
  • Acute myeloid leukaemia · Factor VIII deficiency · HIV infection
  • Adults and children

About Specializations

Rheinische Friedrich-Wilhelms-Universitaet Bonn in Bonn, Germany specialises in clinical trials of conditions such as Acute myeloid leukaemia, Factor VIII deficiency, HIV infection, Hepatocellular carcinoma, and other specialisations. This site conducts important research.

Main research areas of the site

Cardiovascular Research

The department investigates cardiovascular diseases with a focus on improving outcomes after high‑risk cardiac surgery. One study evaluates whether an intravenous fish‑oil lipid emulsion can reduce the incidence of postoperative arrhythmias such as atrial fibrillation.

  • Prevention of atrial fibrillation after cardiac procedures
  • Optimization of peri‑operative lipid therapy
  • Critical care strategies for intensive‑care unit patients

Rheinische Friedrich‑Wilhelms‑Universität Bonn leverages over 100 investigators to advance cardiac recovery research in collaboration with commercial partners.

Oncology and Hematology

In the field of neoplasms, the site conducts trials aimed at enhancing treatment effectiveness for rare and resistant cancers. Research includes a comparison of carboplatin versus cisplatin in patients with malignant extracranial germ‑cell tumours and a study of pembrolizumab combined with chemotherapy for platinum‑resistant ovarian carcinoma.

  • Comparative efficacy of platinum‑based chemotherapy
  • Integration of immunotherapy in recurrent ovarian cancer
  • Biomarker‑driven approaches for germ‑cell tumor management

As an educational institution with commercial collaboration, the Bonn pediatric hematology/oncology department engages more than a hundred investigators to drive innovative cancer therapies.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Venusberg-Campus 1, Venusberg53127 BonnGermany
Recruiting now
181 trials
Conditions studied
259
Partner status
Verified site

More sites in BonnGermany

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

382 clinical trials

Study of lunsekimig versus placebo in adults with inadequately controlled eosinophilic COPD

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Lunsekimig
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Phase 3 study of ZL-1310 versus topotecan hydrochloride in patients with relapsed small cell lung cancer

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Topotecan Hydrochloride
  • Sponsor:Zai Lab (US) LLC

Hidradenitis

Recruiting

Long-term Safety and Efficacy of Remibrutinib in Adults with Moderate to Severe Hidradenitis Suppurativa

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Remibrutinib
  • Sponsor:Novartis Pharma AG

A study to evaluate the effectiveness and safety of pridopidine hydrochloride in patients with amyotrophic lateral sclerosis

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Sponsor:Ferrer Internacional S.A.

A study to evaluate the long-term safety and effectiveness of barzolvolimab in patients with chronic spontaneous urticaria

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Barzolvolimab
  • Sponsor:Celldex Therapeutics Inc.

A Study Testing How Well Bimekizumab Works and How Safe It Is for Adults with Palmoplantar Pustulosis

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Bimekizumab
  • Sponsor:UCB Biopharma

Uveal melanoma

Recruiting

A Study of Darovasertib Before Surgery or Radiation Therapy for Patients with Early-Stage Uveal Melanoma That Has Not Spread

InvestigationalNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Darovasertib
  • Sponsor:Ideaya Biosciences Inc.

Study of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Zilebesiran
  • Sponsor:Alnylam Pharmaceuticals Inc.

Study of laroprovstat (AZD0780) to reduce heart attack, stroke and vascular complications in patients with atherosclerotic cardiovascular disease or high risk of developing it

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Sponsor:AstraZeneca AB

Bronchiectasis

Recruiting

Study of BI 1291583 tablets taken once daily for 76 weeks in adults with bronchiectasis

Investigational
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:BI 1291583
  • Sponsor:Boehringer Ingelheim Espana S.A.

Study of maridebart cafraglutide to reduce cardiovascular problems in overweight or obese patients with atherosclerotic cardiovascular disease

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Maridebart Cafraglutide
  • Sponsor:Amgen Inc.

Study of Ifinatamab Deruxtecan and Chemotherapy for Patients with Advanced or Metastatic Esophageal Squamous Cell Carcinoma

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Docetaxel
  • Sponsor:Daiichi Sankyo Inc.
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.